Post

New research · Ophthalmology
Acta ophthalmologica · 2d
Cross-sectionalActa ophthalmologica · 2026

Childhood ocular safety after postnatal exposure to topical dexamethasone during retinopathy of prematurity screening.

Mariya Petrishka-Lozenska, Anders K Nilsson, Ann Hellström, Pia Lundgren
Read paper
OphthalmologyCross-sectional

Topical dexamethasone during retinopathy of prematurity screening did not raise eye pressure or cause glaucoma.

Childhood ocular safety after postnatal exposure to topical dexamethasone during retinopathy of prematurity screening.

Mariya Petrishka-Lozenska … Pia Lundgren
Acta ophthalmologica · 2026
Purpose

Dexamethasone eye drops are being introduced off-label to prevent progression of severe retinopathy of prematurity (retinopathy of prematurity).

Methods

This prospective cross-sectional follow-up study included preterm infants born between 2019 and 2022 in the Västra Götaland region, Sweden, who received topical dexamethasone off-label during retinopathy of prematurity screening.

Results
18.9
mmHg
eye pressure stayed in a normal, healthy range - no sign of glaucoma
More results

Twenty-four infants (median gestational age 25.0 weeks, range 22.6-27.7 weeks; 58% male) were examined at a median age of 2.9 years (range 1.1-5.0 years).

More results

Dexamethasone eye drops were initiated mainly for severe retinopathy of prematurity at a median postmenstrual age of 35.1 weeks (range 32.0-52.0 weeks) and given for a median duration of 28 days (range 4-136 days).

One child had a unilateral peripheral lens opacity without visual significance.

“
Conclusion · 1 of 2

Preliminary data from extremely preterm infants exposed to off-label topical dexamethasone during retinopathy of prematurity screening showed no clinically significant ocular adverse effects at standardized early childhood follow-up.

Conclusion · 2 of 2

Rates of strabismus and refractive errors were lower than expected. Larger studies with longer follow-up are needed to further assess ocular and systemic safety.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment